Global Transthyretin Amyloidosis Treatment Market Size, Share, and COVID-19 Impact Analysis, By Type (ATTR-PN, ATTR-CM), By Therapy (Targeted, Supportive, And Pipeline), By Disease Type (Hereditary Transthyretin Amyloidosis, and Wild-Type Amyloidosis), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Industry: Healthcare
RELEASE DATE Mar 2024
REPORT ID SI4016
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Therapy
      3. Market Attractiveness Analysis By Disease Type
      4. Market Attractiveness Analysis By Distribution Channel
      5. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing prevalence of transthyretin amyloidosis in geriatric patients
      2. Several initiatives and awareness regarding transthyretin amyloidosis disease
    3. Restraints
      1. Lack of awareness among healthcare professionals
      2. High costs of newly launched drugs
    4. Opportunities
      1. Extensive research for the development of new therapies and drugs for the treatment of transthyretin
    5. Challenges
      1. Lack of qualified healthcare professionals
  6. Global Transthyretin Amyloidosis Treatment Market Analysis and Projection, By Type
    1. Segment Overview
    2. ATTR-PN
    3. ATTR-CM
  7. Global Transthyretin Amyloidosis Treatment Market Analysis and Projection, By Therapy
    1. Segment Overview
    2. Targeted
    3. Supportive
    4. Pipeline
  8. Global Transthyretin Amyloidosis Treatment Market Analysis and Projection, By Disease Type
    1. Segment Overview
    2. Hereditary Transthyretin Amyloidosis
    3. Wild-Type Amyloidosis
  9. Global Transthyretin Amyloidosis Treatment Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Specialty Pharmacies
    4. Retail Pharmacies
    5. Online Pharmacies
  10. Global Transthyretin Amyloidosis Treatment Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  11. Global Transthyretin Amyloidosis Treatment Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Transthyretin Amyloidosis Treatment Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  12. Company Profiles
    1. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   AstraZeneca 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Johnson & Johnson Services, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   SOM Biotech 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Astellas Pharma, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Acrotech Biopharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Ionis Pharmaceuticals, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Alnylam Pharmaceuticals, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Prothena
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  BridgeBio Pharma, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Bristol-Myers Squibb Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Abbvie, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  BELLUS Health Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Eidos Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Bausch Health Company 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Transthyretin Amyloidosis Treatment Market, By Type, 2022-203(USD Billion)
  2. Global ATTR-PN, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  3. Global ATTR-CM, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  4. Global Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  5. Global Targeted, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  6. Global Supportive, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  7. Global Pipeline, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  8. Global Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  9. Global Hereditary Transthyretin Amyloidosis, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  10. Global Wild-Type Amyloidosis, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  11. Global Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  12. Global Hospital Pharmacies, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  13. Global Specialty Pharmacies, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  14. Global Retail Pharmacies, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  15. Global Online Pharmacies, Transthyretin Amyloidosis Treatment Market, By Region, 2022-2032(USD Billion)
  16. North America Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  17. North America Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  18. North America Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  19. North America Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  20. U.S.  Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  21. U.S.  Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  22. U.S.  Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  23. U.S.  Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  24. Canada Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  25. Canada Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  26. Canada Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  27. Canada Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  28. Mexico Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  29. Mexico Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  30. Mexico Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  31. Mexico Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  32. Europe Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  33. Europe Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  34. Europe Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  35. Europe Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  36. Germany Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  37. Germany Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  38. Germany Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  39. Germany Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  40. France Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  41. France Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  42. France Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  43. France Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  44. U.K.  Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  45. U.K.  Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  46. U.K.  Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  47. U.K.  Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  48. Italy Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  49. Italy Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  50. Italy Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  51. Italy Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  52. Spain Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  53. Spain Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  54. Spain Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  55. Spain Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  56. Asia Pacific Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  57. Asia Pacific Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  58. Asia Pacific Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  59. Asia Pacific Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  60. Japan Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  61. Japan Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  62. Japan Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  63. Japan Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  64. China Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  65. China Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  66. China Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  67. China Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  68. India Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  69. India Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  70. India Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  71. India Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  72. South America Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  73. South America Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  74. South America Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  75. South America Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  76. Brazil Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  77. Brazil Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  78. Brazil Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  79. Brazil Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  80. The Middle East and Africa Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD   Billion)
  81. The Middle East and Africa Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD   Billion)
  82. The Middle East and Africa Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  83. The Middle East and Africa Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)
  84. UAE Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  85. UAE Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  86. UAE Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  87. UAE Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion) 
  88. South Africa Transthyretin Amyloidosis Treatment Market, By Type, 2022-2032(USD Billion)
  89. South Africa Transthyretin Amyloidosis Treatment Market, By Therapy, 2022-2032(USD Billion)
  90. South Africa Transthyretin Amyloidosis Treatment Market, By Disease Type, 2022-2032(USD Billion)
  91. South Africa Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2022-2032(USD Billion)

List of Figures 

  1. Global Transthyretin Amyloidosis Treatment Market Segmentation
  2. Transthyretin Amyloidosis Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Transthyretin Amyloidosis Treatment Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Transthyretin Amyloidosis Treatment Market
  20. Transthyretin Amyloidosis Treatment Market Segmentation, By Type
  21. Transthyretin Amyloidosis Treatment Market For ATTR-PN, By Region, 2022-2032 ($ Billion)
  22.  Transthyretin Amyloidosis Treatment Market For ATTR-CM, By Region, 2022-2032 ($ Billion)
  23.  Transthyretin Amyloidosis Treatment Market Segmentation, By Therapy
  24.  Transthyretin Amyloidosis Treatment Market For Targeted, By Region, 2022-2032 ($ Billion)
  25.  Transthyretin Amyloidosis Treatment Market For Supportive, By Region, 2022-2032 ($ Billion)
  26. Transthyretin Amyloidosis Treatment Market For Pipeline, By Region, 2022-2032 ($ Billion)
  27. Transthyretin Amyloidosis Treatment Market Segmentation, By Disease Type
  28. Transthyretin Amyloidosis Treatment Market For Hereditary Transthyretin Amyloidosis, By Region, 2022-2032 ($ Billion)
  29. Transthyretin Amyloidosis Treatment Market For Wild-Type Amyloidosis, By Region, 2022-2032 ($ Billion)
  30. Transthyretin Amyloidosis Treatment Market Segmentation, By Distribution Channel
  31. Transthyretin Amyloidosis Treatment Market For Hospital Pharmacies, By Region, 2022-2032 ($ Billion)
  32. Transthyretin Amyloidosis Treatment Market For Specialty Pharmacies, By Region, 2022-2032 ($ Billion)
  33. Transthyretin Amyloidosis Treatment Market For Retail Pharmacies, By Region, 2022-2032 ($ Billion)
  34. Transthyretin Amyloidosis Treatment Market For Online Pharmacies, By Region, 2022-2032 ($ Billion)
  35. Pfizer Inc.: Net Sales, 2022-2032 ($ Billion)
  36. Pfizer Inc.: Revenue Share, By Segment, 2022 (%)
  37. Pfizer Inc.: Revenue Share, By Region, 2022 (%)
  38. AstraZeneca: Net Sales, 2022-2032 ($ Billion)
  39. AstraZeneca: Revenue Share, By Segment, 2022 (%)
  40. AstraZeneca: Revenue Share, By Region, 2022 (%)
  41. Johnson & Johnson Services, Inc.: Net Sales, 2022-2032 ($ Billion)
  42. Johnson & Johnson Services, Inc.: Revenue Share, By Segment, 2022 (%)
  43. Johnson & Johnson Services, Inc.: Revenue Share, By Region, 2022 (%)
  44. SOM Biotech: Net Sales, 2022-2032 ($ Billion)
  45. SOM Biotech: Revenue Share, By Segment, 2022 (%)
  46. SOM Biotech: Revenue Share, By Region, 2022 (%)
  47. Astellas Pharma, Inc.: Net Sales, 2022-2032 ($ Billion)
  48. Astellas Pharma, Inc.: Revenue Share, By Segment, 2022 (%)
  49. Astellas Pharma, Inc.: Revenue Share, By Region, 2022 (%)
  50. Acrotech Biopharma: Net Sales, 2022-2032 ($ Billion)
  51. Acrotech Biopharma: Revenue Share, By Segment, 2022 (%)
  52. Acrotech Biopharma: Revenue Share, By Region, 2022 (%)
  53. Ionis Pharmaceuticals, Inc.: Net Sales, 2022-2032 ($ Billion)
  54. Ionis Pharmaceuticals, Inc.: Revenue Share, By Segment, 2022 (%)
  55. Ionis Pharmaceuticals, Inc.: Revenue Share, By Region, 2022 (%)
  56. Alnylam Pharmaceuticals, Inc.: Net Sales, 2022-2032 ($ Billion)
  57. Alnylam Pharmaceuticals, Inc.: Revenue Share, By Segment, 2022 (%)
  58. Alnylam Pharmaceuticals, Inc.: Revenue Share, By Region, 2022 (%)
  59. Prothena.: Net Sales, 2022-2032 ($ Billion)
  60. Prothena.: Revenue Share, By Segment, 2022 (%)
  61. Prothena.: Revenue Share, By Region, 2022 (%)
  62. BridgeBio Pharma, Inc.: Net Sales, 2022-2032 ($ Billion)
  63. BridgeBio Pharma, Inc.: Revenue Share, By Segment, 2022 (%)
  64. BridgeBio Pharma, Inc.: Revenue Share, By Region, 2022 (%)
  65. Bristol-Myers Squibb Company: Net Sales, 2022-2032 ($ Billion)
  66. Bristol-Myers Squibb Company: Revenue Share, By Segment, 2022 (%)
  67. Bristol-Myers Squibb Company: Revenue Share, By Region, 2022 (%)
  68. Abbvie, Inc.: Net Sales, 2022-2032 ($ Billion)
  69. Abbvie, Inc.: Revenue Share, By Segment, 2022 (%)
  70. Abbvie, Inc.: Revenue Share, By Region, 2022 (%)
  71. BELLUS Health Inc.: Net Sales, 2022-2032 ($ Billion)
  72. BELLUS Health Inc.: Revenue Share, By Segment, 2022 (%)
  73. BELLUS Health Inc.: Revenue Share, By Region, 2022 (%)
  74. Eidos Therapeutics: Net Sales, 2022-2032 ($ Billion)
  75. Eidos Therapeutics: Revenue Share, By Segment, 2022 (%)
  76. Eidos Therapeutics: Revenue Share, By Region, 2022 (%)
  77. Bausch Health Company: Net Sales, 2022-2032 ($ Billion)
  78. Bausch Health Company: Revenue Share, By Segment, 2022 (%)
  79. Bausch Health Company: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:6.56%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies